Form 6-K NOVO NORDISK A S For: Nov 13
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Mikael Dolsten withdraws board candidacy at Novo Nordisk
November 14, 2025 6:19 AM ESTMikael Dolsten has withdrawn his candidacy for Novo Nordisk's (NYSE: NVO) Board of Directors due to personal circumstances, the Danish pharmaceutical company announced.
Dolsten, who previously served as Head of Research and Development at Pfizer, informed Novo Nordisk that he would not seek election... More
